Recent advances in understanding how interleukin 13 signals are involved in the pathogenesis of bronchial asthma
- PMID: 11197605
Recent advances in understanding how interleukin 13 signals are involved in the pathogenesis of bronchial asthma
Abstract
The prevalence of allergic disease has dramatically increased in recent decades, especially in urban and industrialized areas. Allergic diseases are disorders of the immune system, the results of complex interactions among various genetic and environmental factors. Among them, the important role of interleukin 13 (IL-13), a Th2-type cytokine, has recently emerged in the pathogenesis of bronchial asthma. Based on studies using mice, great attention has been paid to the direct effects of IL-13 on bronchial tissues. In this review, we describe recent advances in understanding the signal transduction mechanism of IL-13, the involvement of IL-13 signal-related genes as genetic factors in the pathogenesis of bronchial asthma, and the expression of IL-13 receptor on bronchial tissues. We describe potential strategies for targeting IL-13 signals to improve allergic states.
Similar articles
-
[Involvement of interleukin-4, and -13 in the pathogenesis of allergic diseases].Rinsho Byori. 2001 Apr;49(4):360-4. Rinsho Byori. 2001. PMID: 11391949 Japanese.
-
[Involvement of IL-4 and IL-13 signals in the pathogenesis of bronchial asthma].Arerugi. 2005 Jan;54(1):7-11. Arerugi. 2005. PMID: 15841670 Review. Japanese. No abstract available.
-
[Inflammatory cytokines (IL-4, IL-5 and IL-13)].Nihon Rinsho. 2001 Oct;59(10):1894-9. Nihon Rinsho. 2001. PMID: 11676128 Review. Japanese.
-
Interleukin-13 in asthma pathogenesis.Immunol Rev. 2004 Dec;202:175-90. doi: 10.1111/j.0105-2896.2004.00215.x. Immunol Rev. 2004. PMID: 15546393 Review.
-
Cytokine regulation of mucus production in a model of allergic asthma.Novartis Found Symp. 2002;248:201-13; discussion 213-20, 277-82. Novartis Found Symp. 2002. PMID: 12568496